Sponsors & Exhibitors
Gulf Drugestablished in 1969, under the visionary leadership of its founder, the Late Dr. Hassan Al Moosa. The company is one of the first to have started Pharmacies, Private Clinics, Healthcare Marketing and Distribution Services in the U.A.E. Gulf Drug proudly achieves success from its Business Entities.
- Pharma & Consumer Healthcare
- Pharma Institutional
- Medical Equipment
- Medical Supplies & Instruments
- Veterinary Health
Medical Equipment Business
Having three decades of extensive experience and in collaboration with the world's best medical technology providers, we have successfully accomplished in setting our name as one among the resilient and responsibleentity of the health care sector.
Fresenius Medical Care is the world's leading provider of products and services for people with chronic and Acute kidney failure. Around 3 million patients with this disease worldwide regularly undergo dialysis treatment.
We care for more than 310,000 patients in our global network of more than 3,600 dialysis clinics. At the same time, we operate 37 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.
- We offer dialysis services and products in more than 120 countries.
- Every 0.7 seconds we provide a dialysis treatment somewhere on the globe.
- In 2016, 50% of the dialysis machines sold worldwide were produced by Fresenius Medical Care
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its manufacturing expertise to strive for solutions dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Abstracts Submission Deadline
30th Sept 2017
15th Oct 2017
Early Bird Registration
15th Oct 2017